Employers Debate the Costs and Benefits of Covering Obesity Drugs
Allwork
JANUARY 11, 2024
This is mainly because employers are grappling with the high costs of covering obesity drugs against their potential health savings. This approach reveals a controversial balancing act between providing employee health benefits and managing high healthcare costs. A report released Wednesday by JPMorgan Chase & Co.’s
Let's personalize your content